Rivaroxaban, Apixaban Associated With Lower Brain Bleed Risk Than Warfarin in NVAF Rivaroxaban, Apixaban Associated With Lower Brain Bleed Risk Than Warfarin in NVAF

Rivaroxaban and apixaban are associated with a lower risk of intracranial hemorrhage (ICH) than warfarin in patients with nonvalvular atrial fibrillation (NVAF), according to a new study.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Neurology & Neurosurgery News Source Type: news